Brunt, Elizabeth M.

Publishing since 1995 (Senior)

Has published 110 publications in 16 years

Number of publications published per year by Brunt, Elizabeth M.. (Source : PubMed)

Distribution of publications types for Brunt, Elizabeth M.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Hanada S, Snider NT, Brunt EM, Hollenberg PF, Omary MB. Gender dimorphic formation of mouse Mallory-Denk bodies and the role of xenobiotic metabolism and oxidative stress.  Gastroenterology  2010;138;4  
•  Brunt EM. Pathology of nonalcoholic fatty liver disease.  Nat Rev Gastroenterol Hepatol  2010  
•  Hall AM, Brunt EM, Chen Z, Viswakarma N, Reddy JK, Wolins NE, Finck BN. Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice.  J. Lipid Res.  2010;51;3  
•  Everhart JE, Wright EC, Goodman ZD, Dienstag JL, Hoefs JC, Kleiner DE, Ghany MG, Mills AS, Nash SR, Govindarajan S, Rogers TE, Greenson JK, Brunt EM, Bonkovsky HL, Morishima C, Litman HJ. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.  Hepatology  2010;51;2  
•  Hall AM, Brunt EM, Klein S, Finck BN. Hepatic expression of cell death-inducing DFFA-like effector C in obese subjects is reduced by marked weight loss.  Obesity (Silver Spring)  2010;18;2  
•  Lavine JE, Schwimmer JB, Molleston JP, Scheimann AO, Murray KF, Abrams SH, Rosenthal P, Sanyal AJ, Robuck PR, Brunt EM, Unalp A, Tonascia J. Treatment of nonalcoholic fatty liver disease in children: TONIC trial design.  Contemp Clin Trials  2010;31;1  
•  Tiniakos DG, Vos MB, Brunt EM. Nonalcoholic fatty liver disease: pathology and pathogenesis.  Annual review of pathology  2010;5  
•  Goodman ZD, Stoddard AM, Bonkovsky HL, Fontana RJ, Ghany MG, Morgan TR, Wright EC, Brunt EM, Kleiner DE, Shiffman ML, Everson GT, Lindsay KL, Dienstag JL, Morishima C. Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial.  Hepatology  2009;50;6  
•  Johnston FM, Tan MC, Tan BR, Porembka MR, Brunt EM, Linehan DC, Simon PO, Plambeck-Suess S, Eberlein TJ, Hellstrom KE, Hellstrom I, Hawkins WG, Goedegebuure P. Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer.  Clin. Cancer Res.  2009;15;21  
•  Brunt EM. Histopathology of non-alcoholic fatty liver disease.  Clin Liver Dis  2009;13;4  

[ See timeline ] [ See all publications ]